Welcome to the Bio-based Material China Quarterly Report Q3 2026
Policy
In July, China issued five national policies to promote bio‑based development, covering raw material supply, material quality, application scenarios, and downstream demand.
On 18 August, Hechi Municipal Government issued its 15th Five‑Year Plan for chemical industry development, explicitly aiming to leverage the city's abundant non‑grain biomass resources to establish Hechi City as a demonstration base for high‑value biomass fractionation and utilization in Guangxi Province.
Market & Corporate updates
In August, seven bio-based materials companies disclosed their 2026 semi-annual reports. In H1, the net profit attributable to the parent company of Kingfa, Levima, Cathay Biotech, and HISUN increased YoY, while that of Hefei Hengxin, Henan Jindan, and Ningke decreased YoY.
In Q3 2026, the following domestic bio-based projects made new progress.
Jiangsu Special plans to add 6,000 t/a bio-based 1,2-pentanediol capacity.
BBCA Biochemical's 60,000 t/a PLA modified material project tops out.
Liaoning Kingfa's bio-based BDO technical renovation project gets EI approval.
Shandong Huaxian proposes to build 10,000 t/a PLA filament capacity.
The USD/CNY exchange rate used is USD1.00=RMB6.7809 (sourced from People's Bank of China on 1 September, 2026). All prices include VAT unless otherwise stated.

